R Tal-Singer Lung Health Researcher & Advocate 🫁

A Scientific leader, innovator & expert in the Respiratory field. Driver of pre-competitive patient-focused international partnerships and collaborations.

[R Tal-Singer Lung Health Researcher & Advocate 🫁 @rtalsinger1]

“One exacerbation is one too many” at #GOLDCOPD2026 (Proof Halpin)
People with #COPD deserve optimal care
@gaapporg

[R Tal-Singer Lung Health Researcher & Advocate 🫁 @rtalsinger1]

Global #Patient_registries put #bronchiectasis and its phenotypes like BE #COPD overlap on the map.. BE now featured at #GOLDCOPD2026. Awareness leads to optimal diagnosis and care delivery 👏👏👏

@EMBARCnetwork
@ProfJDChalmers

[Global Allergy & Airways Patient Platform @gaapporg]

Day 1 in Philadelphia at the GOLD International COPD Conference, hosted by @GOLD_COPD. Our team is on-site representing GAAPP and Speak Up for COPD! If you're attending the conference, make sure to stop by our booths to connect with us. #SpeakUpForCOPD

[R Tal-Singer Lung Health Researcher & Advocate 🫁 @rtalsinger1]

Investment in good disease understanding studies pays off #ECLIPSE_COPD is still relevant 16 years after it completed

[R Tal-Singer Lung Health Researcher & Advocate 🫁 @rtalsinger1]

A welcome summary by Prof Celli of the Rome proposal redefinition of #AECOPD severity at #GOLD2026 .., the #CERT might be useful in bringing the #COPD patient to the point of care…
@gaapporg @GOLD_COPD

[R Tal-Singer Lung Health Researcher & Advocate 🫁 @rtalsinger1]

Excellent session on #mucus-plugging at #GOLD2026 but the missing link is how does it become a validated quantitative endpoint!
#IREN @gaapporg are all plugs tge same???

[R Tal-Singer Lung Health Researcher & Advocate 🫁 @rtalsinger1]

Day 1 of #GOLD2026 with my @gaapporg colleagues spreading our mission of improving the lives of people living with #COPD worldwide 🌍

[Global Allergy & Airways Patient Platform @gaapporg]

Some GAAPP email accounts were compromised. We're investigating with cybersecurity experts and upgrading our systems. GAAPP will NEVER ask for money or private info via email. If you get a suspicious message, disregard it and verify with us directly. Thank you.

[Global Allergy & Airways Patient Platform @gaapporg]

#AskMeAnythingEczema: How can families manage eczema in low-resource settings? Dr. Evelyne Ng'ang'a explains. Stay tuned for more Q&A videos about atopic eczema on our socials today.
Learn more: https://t.co/2ofp1INLzy

[Global Allergy & Airways Patient Platform @gaapporg]

#AskMeAnythingEczema: This World Atopic Eczema Day, get ready to chat with Dr. Anahi Yáñez, from Argentina. Drop your Q below! https://t.co/2ofp1INLzy
.
*This forum does not replace a one-on-one consultation with your own healthcare professional.

[R Tal-Singer Lung Health Researcher & Advocate 🫁 @rtalsinger1]

Great editors session at #ERS2026 on this eventful day of good news for people with #copd
#earlydiagnosis

[R Tal-Singer Lung Health Researcher & Advocate 🫁 @rtalsinger1]

An inspiring day.. the future of Respiratory research is bright!

[Global Allergy & Airways Patient Platform @gaapporg]

#ICAN2026: From abstracts to "speed dating," we explored precision respiratory medicine across asthma, COPD, bronchiectasis & PCD. Highlights: EV proteomes, single-cell signatures, GLP-1RAs, spatial transcriptomics & more. Thank you to our participants, mentors, & supporters!

[R Tal-Singer Lung Health Researcher & Advocate 🫁 @rtalsinger1]

The #CAAT in #bronchiectasis late breaker.. psychometric validation ✅
With the great Prof Paul Jones of @gaapporg and @ProfJDChalmers of @EMBARCnetwork

[James D Chalmers @ProfJDChalmers]

First day and already I know this will be my favourite session of the congress
Thank you to all of our patients and tk @EuropeanLung - you’ve changed the clinical and scientific landscape in bronchiectasis and many other respiratory diseases ❤️

[R Tal-Singer Lung Health Researcher & Advocate 🫁 @rtalsinger1]

New publication! Proud to contribute to research showing how COPDCompEx better captures meaningful worsening in COPD and strengthens patient-centred clinical trials.

https://t.co/EkS6SFw009

#COPD #PatientVoice #ClinicalResearch @gaapporg

[R Tal-Singer Lung Health Researcher & Advocate 🫁 @rtalsinger1]

Interesting perspective on disease progression.. @ProfJDChalmers do we need a disease-specific composite outcome in #bronchiectasis ?
#WBConf26
#IREN @gaapporg

[R Tal-Singer Lung Health Researcher & Advocate 🫁 @rtalsinger1]

Dr Raquel Duarte from Portugal made an important point about engaging patients and caregivers in mapping treatment for advanced refractory NTM disease at the #WBConf26 session “what keeps us awake at night”

[R Tal-Singer Lung Health Researcher & Advocate 🫁 @rtalsinger1]

@becleartoday You are missed in person Linda but your posters and image are with us!! Your voice is present at #WBConf26 🙏

[R Tal-Singer Lung Health Researcher & Advocate 🫁 @rtalsinger1]

Excellent insightful talk on social issues from Victoria Campbell (Hannover Medical School) at the “psychosocial impact of living with #bronchiectasis “ at #WBConf26 “you are a person who has bronchiectasis not bronchiectasis that happens to a person”

[Oriol Sibila @OSibila]

Exacerbations are critical in #Bronchiectasis, and each prior exacerbation counts on future risk, especially the severe ones.
Thrilled to present our last #EMBARC paper at the #WBConf26 journal session, published today at the #AJRCCM @ATSBlueEditor

👉https://t.co/PypRhKi92W